Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Xeris Biopharma Holdings Inc., 3 years.
Xeris Biopharma Holdings Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 4, 2026 | Xeris Biopharma Holdings Inc. | Open-market sale | −20,000 | $6.09 | $121,800 |
| Jun 4, 2026 | Xeris Biopharma Holdings Inc. | Grant or award | +24,193 | — | — |
| Aug 12, 2025 | Xeris Biopharma Holdings Inc. | Open-market sale | −42,500 | $7.28 | $309,400 |
| Jun 4, 2025 | Xeris Biopharma Holdings Inc. | Grant or award | +50,000 | — | — |
| Jun 5, 2024 | Xeris Biopharma Holdings Inc. | Grant or award | +50,000 | — | — |
| Nov 20, 2023 | Xeris Biopharma Holdings Inc. | Open-market purchase | +5,410 | $1.84 | $9,954 |
| Jun 7, 2023 | Xeris Biopharma Holdings Inc. | Grant or award | +42,500 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.